Cargando…
Rational development of a combined mRNA vaccine against COVID-19 and influenza
As the world continues to experience the COVID-19 pandemic, seasonal influenza remain a cause of severe morbidity and mortality globally. Worse yet, coinfection with SARS-CoV-2 and influenza A virus (IAV) leads to more severe clinical outcomes. The development of a combined vaccine against both COVI...
Autores principales: | Ye, Qing, Wu, Mei, Zhou, Chao, Lu, Xishan, Huang, Baoying, Zhang, Ning, Zhao, Hui, Chi, Hang, Zhang, Xiaojing, Ling, Dandan, Zhang, Rong-Rong, Li, Zhuofan, Luo, Dan, Huang, Yi-Jiao, Qiu, Hong-Ying, Song, Haifeng, Tan, Wenjie, Xu, Ke, Ying, Bo, Qin, Cheng-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315335/ https://www.ncbi.nlm.nih.gov/pubmed/35882870 http://dx.doi.org/10.1038/s41541-022-00478-w |
Ejemplares similares
-
Rational development of multicomponent mRNA vaccine candidates against mpox
por: Zhang, Rong-Rong, et al.
Publicado: (2023) -
Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD
por: Li, Yulei, et al.
Publicado: (2023) -
Construction and immunogenicity of an mRNA vaccine against chikungunya virus
por: Liu, Jingjing, et al.
Publicado: (2023) -
Development and optimized pairing of mouse monoclonal antibodies for detecting hemagglutinin in novel H7 subtype influenza viruses
por: Wang, Huijuan, et al.
Publicado: (2019) -
Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats
por: Wang, Wenling, et al.
Publicado: (2019)